WASHINGTON (Reuters) – The United States has proposed analyzing genetic information from more than 1 million American volunteers as part of a new initiative to understand human disease and develop medicines targeted to an individual’s genetic make-up.
At the heart of the initiative, to be announced on Friday by President Barack Obama, is the creation of a pool of people – healthy and ill, men and women, old and young – who would be studied to learn how genetic variants affect health and disease.
‘Information solicited by employers’ for wellness programs ‘not even related to wellness’: #Senate hearing
NEW YORK (Reuters) – Some insurers selling policies under Obamacare may be structuring drug coverage in a way that dissuades people with HIV-AIDS from becoming their customers, according to a study published on Wednesday in the New England Journal of Medicine.
President Barack Obama’s 2010 Affordable Care Act outlawed discrimination based on pre-existing conditions. Insurers cannot ask about current or past illnesses, charge people with, say, diabetes or cancer more than healthy people, or deny coverage.
NEW YORK (Reuters) – When patients with Parkinson’s disease received an injection described as an effective drug costing $1,500 per dose, their motor function improved significantly more than when they got one supposedly costing $100, scientists reported on Wednesday.
Underlining the power of expectations, the motor improvements, measured by a standard Parkinson’s assessment, occurred even though both injections contained only saline and no active ingredients.